CLINICAL TRIAL article

Front. Integr. Neurosci., 29 January 2014

Volume 8 - 2014 | https://doi.org/10.3389/fnint.2014.00004

Galvanic vestibular stimulation in hemi-spatial neglect

  • DW

    David Wilkinson 1*

  • OZ

    Olga Zubko 1

  • MS

    Mohamed Sakel 2

  • SC

    Simon Coulton 3

  • TH

    Tracy Higgins 3

  • PP

    Patrick Pullicino 2

  • 1. School of Psychology, University of Kent Canterbury, UK

  • 2. East Kent Neuro-Rehabilitation Service, East Kent Hospitals University NHS Foundation Trust Canterbury, UK

  • 3. Centre for Health Services Studies, University of Kent Canterbury, UK

Abstract

Hemi-spatial neglect is an attentional disorder in which the sufferer fails to acknowledge or respond to stimuli appearing in contralesional space. In recent years, it has become clear that a measurable reduction in contralesional neglect can occur during galvanic vestibular stimulation, a technique by which transmastoid, small amplitude current induces lateral, attentional shifts via asymmetric modulation of the left and right vestibular nerves. However, it remains unclear whether this reduction persists after stimulation is stopped. To estimate longevity of effect, we therefore conducted a double-blind, randomized, dose-response trial involving a group of stroke patients suffering from left-sided neglect (n = 52, mean age = 66 years). To determine whether repeated sessions of galvanic vestibular stimulation more effectively induce lasting relief than a single session, participants received 1, 5, or 10 sessions, each lasting 25 min, of sub-sensory, left-anodal right-cathodal noisy direct current (mean amplitude = 1 mA). Ninety five percent confidence intervals indicated that all three treatment arms showed a statistically significant improvement between the pre-stimulation baseline and the final day of stimulation on the primary outcome measure, the conventional tests of the Behavioral Inattention Test. More remarkably, this change (mean change = 28%, SD = 18) was still evident 1 month later. Secondary analyses indicated an allied increase of 20% in median Barthel Index (BI) score, a measure of functional capacity, in the absence of any adverse events or instances of participant non-compliance. Together these data suggest that galvanic vestibular stimulation, a simple, cheap technique suitable for home-based administration, may produce lasting reductions in neglect that are clinically important. Further protocol optimization is now needed ahead of a larger effectiveness study.

Introduction

Hemi-spatial neglect is a debilitating, attentional disorder that most commonly arises from damage to the right-side of the brain (Robertson and Halligan, 1999). Sufferers fail to acknowledge or respond to visual information presented on the side of space opposite their brain lesion (e.g., the left), and as such struggle with many daily routines, characteristically bumping into obstacles, failing to notice people on the affected side or cleaning only one side of their body. Prevalence is hard to estimate because diagnostic criteria differ, but conservative estimates indicate that of the ~150,000 UK residents who suffer a stroke per year, approximately 18% (i.e., 27,000) will show moderate to severe left-sided neglect in the acute phase, with ~7% (i.e., 10,000) continuing to show stable impairment beyond 3 months (Ringman et al., 2004). Unfortunately, the presence of left neglect is very strongly associated with poor general functional outcome. Individuals with neglect (regardless of severity) typically require additional weeks in hospital (Katz et al., 1999; Wilkinson et al., 2012), need nearly twice as many hours of physiotherapy and occupational therapy, and are more prone to falls and persistent urinary incontinence (Paolucci et al., 2001). Compared to others with the same Barthel Index (BI) score at hospital admission, patients with neglect score significantly lower on measures of functional independence both during hospital stay and 18 months after leaving (Jehkonen et al., 2000; Gillen et al., 2005; Nijboer et al., 2013). Those who still show neglect on simple bedside tests 2 months after admission have a higher risk of functional worsening at 1 year follow-up. Post discharge, patients with neglect are more likely to require ambulatory assistance and long-term institutionalization or assisted living Kalra et al., 1997; Katz et al., 1999; Nijboer et al., 2013.

Regrettably, many cases of neglect are refractory to treatment. According to a Cochrane Review conducted in 2013, “the effectiveness of rehabilitation strategies for reducing the disabling effects of neglect and increasing independence remains unproven,” (Bowen et al., 2013, p. 1). The review pointed out that although several new treatment approaches meet proof-of-concept, too few studies have progressed these to the level of randomized, controlled trials.

Near complete, but transient, relief from neglect has been observed during artificial stimulation of the vestibular nerves (Rubens, 1985; Cappa et al., 1987). These nerves send information from the semi-circular canals and otoliths of the inner ear to, among other brain regions, parts of the peri-sylvia involved in spatial attention and awareness (Suzuki et al., 2001; Balaban et al., 2011). The conventional method, caloric vestibular stimulation, involves the injection of thermal current (usually via cold water) into the ear canal. This alters the density of endolymph within the nearby balance organs and in turn modulates their afferent firing patterns (see Miller and Ngo, 2007). Unfortunately, the therapeutic benefit of CVS is offset by severe vertigo, nausea and the more general impracticality of ear irrigation, all of which hinder repeated use.

Recent studies suggest that a related technique, known as galvanic vestibular stimulation may provide a more tolerable and simpler way of harnessing this beneficial effect (see Utz et al., 2010). GVS involves the delivery of tiny electrical currents via two small electrodes to the mastoid processes which overlie the vestibular nerves (Coats, 1972). The currents modulate the firing rates of the vestibular nerves in a similar manner to natural head movement, inducing broad-scale compensatory responses across cortical and subcortical regions (Bense et al., 2001; Wilkinson et al., 2012). The electric currents are applied at a level (~1 mA) that is too low to be felt by the patient and without the need for patient agency or motivation which are often compromised in neglect.

Preliminary studies show that a single 15–30 min session of GVS improves performance across a range of visuo-spatial tasks including line bisection, figure copying and target cancellation (Rorsman et al., 1999; Wilkinson et al., 2010; Utz et al., 2011a). Several recent studies also hint, but by no means confirm, that the beneficial effects of GVS persist after stimulation is stopped. In an unblinded study performed on two neglect patients, Zubko et al. (2013) showed that a week's programme of GVS was associated with statistically fewer omissions on the star and letter cancellation tasks 3 days post-stimulation. In two other small-group studies conducted on non-neglectors, Kerkhoff and colleagues showed that GVS induced lasting relief for up to 12 weeks from the somatosensory disorder of tactile extinction (Kerkhoff et al., 2011; Schmidt et al., 2013). Given that these studies provide only indirect support for the idea that GVS can induce lasting carry-over from neglect, the need arises for a more reliable estimate of the duration and magnitude of recovery. If, under more tightly controlled and adequately powered conditions, proof of carry-over can be shown then further investigations into the rehabilitative potential of GVS would be warranted.

Most forms of neuro-rehabilitation tend to rely on repeated application to induce carry-over, a finding that chimes with the recent discovery that experience-dependent, long-term plastic change requires multiple stimulus exposures (Hoffman and Cavus, 2002). In the case of hemi-spatial neglect, several techniques other than GVS (e.g., transcranial magnetic stimulation, optokinetic stimulation) have induced gains, albeit of limited scope, for 2 weeks or more following 5–10 consecutive, 30 min daily sessions (Kleinjung et al., 2005; Shindo et al., 2006; Naeser et al., 2012). Similar treatment periods have induced long-term remission from other neuropsychological disorders (McKay et al., 2002; Ohn et al., 2008). These studies suggest that repeated administration not only increases the length of recovery, but also the magnitude of recovery. Contrary to the preliminary data described above (Kerkhoff et al., 2011; Schmidt et al., 2013; Zubko et al., 2013), these studies imply that GVS may be most effective when repeatedly, as opposed to singularly, applied.

The present study had two specific aims: to establish whether (1) GVS can induce a recovery from neglect that lasts beyond the stimulation period, and (2) carry-over is more effectively induced via a single or repeated sessions. To test these hypotheses we allocated, at random, 52 experimental volunteers with left-sided hemi-spatial neglect to one of three treatment arms in which they received 1, 5, or 10 sessions of subliminal GVS, with those in the 1 and 5 treatment arms also receiving 9 and 5 sham sessions respectively. Follow-up tests and questionnaires were conducted 1, 2, and 4 weeks later to assess the severity of neglect symptoms, transfer to activities of daily living, and compliance.

Materials and methods

Participants

Participants were recruited between July 2011 and November 2012 from nearby acute stroke and neuro-rehabilitation units in South East England, although a handful of participants self-referred from other parts of the UK following national media coverage. Individuals were eligible if they scored ≤129 on the conventional tests of the Behavioral Inattention Test (BIT) (Halligan et al., 1987); suffered a right unilateral stroke (confirmed by CT or MRI scan); ≥6 weeks post-stroke; ≥18 years; scored ≤2 on the 6-item screener for dementia (Callahan et al., 2002), and scored ≤29 on the Beck Depression Inventory (Beck et al., 1996). Individuals with neglect and suspected visual field loss were included because there is evidence that they can still benefit from GVS (e.g., Rorsman et al., 1999; Wilkinson et al., 2005; Utz et al., 2011a). The presence of hemianopia was not recorded for study purposes because formal field perimetry was not available for many participants. Individuals with titanium plates were also included provided these did not lie beneath or directly adjacent to the stimulation sites. Individuals were excluded if they showed evidence of moderate to severe aphasia on clinical examination and/or prior significant neurological or vestibular illness. Patients with electronic implants, such as cardiac pacemakers, were also excluded given the potential for electrical interference from the vestibular stimulator.

Recruitment, allocation, and blinding

All participants were informed of the study and provided written informed consent prior to assessment. The study received NHS ethical approval from the London City & East NRES committee, and was conducted in accordance with Medical Research Council (UK) Good Clinical Practice guidelines and the Declaration of Helsinki. Prior to participant enrolment, the trial was registered on the UK Clinical Research Network Study Portfolio Database (UKCRN ID: 10505).

Patients who met eligibility were randomly assigned to one of the three treatment arms (1 active and 9 sham treatments vs. 5 active and 5 sham treatments vs. 10 active and 0 sham treatments) using minimization controlling for age (60 years or more vs. less than 60 years), inpatient/outpatient status, and severity of neglect as measured by the conventional measures of the BIT. Randomization was conducted using a secure, remote randomization facility independent of the research team.

Treatment allocation was double-blind; since the GVS was sub-sensory participants did not know their allocation, and a stimulation protocol (active or sham) pre-determined by the randomization officer was naively administered by the experimenter by typing a 4 digit code (which changed every time) into the stimulation device. Participants' in-patient neglect treatment (typically visual scanning therapy but sometimes limited to the informal reminders given by occupational therapy staff to look left during functional activities) was suspended while they remained on-study. Treatment begun within 1 week of baseline assessment.

Outcome measures

The primary outcome measure, severity of neglect 4 weeks post-stimulation, was measured using the conventional measures of the BIT. Transfer to activities of daily living was measured using the BI (Mahoney and Barthel, 1965). The BIT and BI were administered by the experimenter at baseline, on the final day of stimulation, and then 1, 2, and 4 weeks post-stimulation. Participant well-being was captured via daily diary cards and an end-of-study satisfaction questionnaire which were completed by the participant often with the help of a relative or friend.

Treatment preparation

Bipolar, binaural current was delivered through a pair of 2 × 4 cm carbon-rubber, self-adhesive, disposable stimulating electrodes placed over participants' mastoid processes. To ensure complete electrical contact with the electrodes, surrounding skin was cleansed with an alcohol swab and conductive gel coated on the undersides of the electrodes. To induce leftward deviation in the lateral plane, the anode was placed over the left mastoid and the cathode over the right mastoid. The electrodes were connected to a Magstim Eldith Transcranial DC Stimulator Plus™ device that was pre-programmed to deliver either 0 or 1 mA mean (0.5–1.5 mA) noisy current for 25 min. Earlier pilot work indicated that older, stroke patients rarely report the presence of a noisy 1 mA DC waveform. In line with this, the incidence with which our participants reported unusual sensations during stimulation, such as pain, tingling or itching behind the ears, were no greater than at the “no stimulation” baseline (see Table 12). Participants were informed that although all participants would receive at least one session of active stimulation, the number of active sessions would vary from participant to participant. During stimulation, participants rested and remained either seated or positioned upright in bed. Stimulation was performed daily from Monday to Friday for two consecutive weeks. All sham sessions were administered first to ensure that, across participants, equal time had elapsed between the final session of active stimulation and the first follow-up assessment. This meant that in the 1 active condition, active stimulation was administered on the final (i.e., 10th) stimulation day, while participants in the 5 active condition received active stimulation from days 6 to 10.

Results

Fifty-five participants were considered eligible, provided consent and randomized (see Figure 1). Of these, 6 participants did not complete the treatment protocol resulting in a total of 49 patients with evaluable data across the three treatment regimens. This number allowed us to meet our target enrolment of 15 participants per treatment arm which was deemed sufficient to allow a potential effect size difference of 0.8 to be detected at 80% power and an alpha of 0.05. The sample demographic characteristics were similar across all three arms (see Table 1).

Figure 1

Table 1

Treatment regimen
1 Active5 Active10 Active
Total N151816
Age (years)Mean66.966.065.7
SD10.69.378.72
Median66.066.566.0
Range333833
Gender (N)Male121213
Female363
Ethnicity (N)White European151816
Patient type (N)Inpatient1099
Outpatient597
Time sinceMedian687594
stroke (days)Interquartile range39–22941–47939–534

Summary of demographic data.

The analysis was conducted as a per protocol analysis, in that only those who completed the intervention and follow-up were evaluated. The primary outcome measure, BIT score at 4 weeks stimulation, was evaluated using an analysis of covariance adjusting for the baseline covariates of BIT score at enrolment, in/out patient status, and age. Analyses of the BI scores were also adjusted for these covariates. Summary data were collated for descriptive analyses of the sub-tests/sub-scales of the BIT and BI, and to show the level of participant satisfaction and the incidence/nature of adverse events. Given the unexpected variation in time since stroke across treatment arm (see Table 1), exploratory analyses were also conducted post hoc using the analysis of covariance described above but with Time since Stroke as an additional co-variate to explore its impact on the primary and secondary outcome measures.

Behavioral inattention test

Table 2 presents measures of central tendency and dispersion for each treatment arm. Table 3 shows the p-values from the corresponding ANCOVA of the adjusted mean scores, and highlights a significant association between mean BIT score at baseline and all subsequent sessions. Adjusted mean BIT scores (change from baseline) and corresponding 95% confidence intervals are shown in Figure 2, and indicate that the change in BIT score between baseline and 4 weeks post-GVS was statistically significant in all treatment arms. These changes were associated with large effect sizes: Cohen's d for 1 active, 5 active, and 10 active arms = 0.97, 1.29, and 1.48, respectively. The pattern of non-overlapping/overlapping confidence intervals in Figure 2 also indicate that the BIT scores at all other time-points were statistically different from baseline, although there were no statistically significant differences between treatment arms (see Table 4). The improvement in overall BIT performance from baseline to week 4 was evident on all sub-tests in all treatment arms, except for figure/shape copying in the 1 active arm, and free drawing in the 5 and 10 active arms (see Table 5). The differences across treatment arms in BIT sub-test scores at baseline and week 4 are depicted in Table 6, and although some appear to be marked, the statistical analysis did not show statistically significant differences. Likewise, the exploratory analysis indicated that Time since Stroke did not significantly affect outcome (see Tables 7, 8).

Table 2

Treatment regimen
1 Active5 Active10 Active
BaselineMean73.378.785.0
SD40.234.035.9
Median818397
Minimum131528
Maximum124125124
Range11111096
N151816
Session 10Mean92.996.397.4
SD38.936.038.1
Median97110113
Minimum213717
Maximum143142140
Range122105123
N151816
Week 1Mean94.910496.9
SD37.331.738.7
Median108122106.5
Minimum155321
Maximum143143139
Range12890118
N151516
Week 2Mean10110297.1
SD36.734.136.0
Median111119106
Minimum195331
Maximum145146138
Range12693107
N151716
Week 4Mean99.699.9104
SD39.835.839.3
Median111113122
Minimum192826
Maximum146144142
Range127116116
N151816
AUC (0–4 weeks)Mean393424395
SD150127147
Median430489460
Minimum73229102
Maximum578577545
Range505348443
N151516

Summary of BIT scores.

AUC, area under the curve.

Table 3

Analysis of covariance (p-values)
TreatmentTreatment (linear)BaselineAgePatient status
Week 40.6780.383<0.0010.07840.0670
AUC (0–4 weeks)0.2540.0964<0.0010.09430.360
Session 100.5660.297<0.0010.05330.645
Week 10.4320.200<0.0010.390.584
Week 20.08650.0261<0.0010.02030.330

Results from statistical analysis of BIT.

Figure 2

Table 4

Adjusted means (95% confidence intervals)
Treatment difference
5 Active – 1 Active10 Active – 1 Active10 Active – 5 Active
Week 4−3.44 (−16.4 to 9.49)−5.83 (−19.1 to 7.48)−2.38 (−15.0 to 10.2)
AUC (0−4 weeks)−15.0 (−64 to 33.9)−39.1 (−86.7 to 8.53)−24.1 (−71.2 to 23.1)
Session 10−1.57 (−14.1 to 10.9)−6.48 (−19.3 to 6.38)−4.92 (−17.1 to 7.28)
Week 1−2.35 (−16.2 to 11.5)−8.35 (−21.8 to 5.09)−5.99 (−19.3 to 7.30)
Week 2−6.54 (−19.1 to 6.06)−14.3 (−27.0 to −1.59)−7.76 (−20.0 to 4.44)

BIT adjusted means and 95% confidence intervals—treatment differences.

Table 5

No. activeBIT sub-tests
Star cancellation (max = 54)Letter cancellation (max = 40)Line bisection (max = 9)Line crossing (max = 36)Copying (max = 4)Free drawing (max = 4)
151015101510151015101510
Baseline242935192426332292435111022
Session10313942253132434353536212222
Week 1423639243026444333535122223
Week 2454538282830443363636122222
Week 4473842253333465353436122222
Week 4-baseline23976971336101011200

Median scores on BIT sub-tests as function of number of active sessions.

Parenthesized values denote maximum possible score. The bottom row shows change from baseline to week 4.

Table 6

No. activeBIT sub-tests
Star cancellationLetter cancellationLine bisectionLine crossingCopyingFree drawing
1–51–105–101–51–105–101–51–105–101–51–105–101–51–105–101–51–105–10
Baseline−5−11−6−5−7−20115−6−11000−2−20
Week 495−4−8−80−2−111−1−2−1−10000

Inter-arm differences in median scores on BIT sub-tests at baseline and week 4.

To illustrate, for star cancellation the median score at baseline was 5 points lower in the 1 active arm compared to the 5 active arm. By week 4, the median score was 9 points higher in the 1 active arm compared to the 5 active arm.

Table 7

Analysis of covariance (p-values)
TreatmentTreatment (linear)BaselineAgePatient statusTime since stroke
Week 40.7330.542<0.0010.0270.2100.714
AUC (0–4 weeks)0.3520.196<0.0010.0610.3690.064

Results from the exploratory statistical analysis of BIT including time since stroke as a co-variate.

Table 8

Adjusted means (95% Confidence intervals) Treatment difference
5 Active – 1 Active10 Active – 1 Active10 Active – 5 Active
Week 4−4.95 (−18.7 to 8.85)−4.46 (−18.6 to 9.69)0.488 (−13.4 to 14.3)
AUC (0−4 weeks)−29.7 (−82.1 to 22.6)−33.3 (−83.2 to 16.5)−3.59 (−54.9 to 47.1)

BIT adjusted means and 95% confidence intervals from the exploratory analysis including time since stroke as a co-variate—treatment differences.

Barthel index

Table 9 presents measures of central tendency and dispersion for each treatment arm. Table 10 shows the p-values for the corresponding ANCOVA and highlights a significant association between baseline BI score and the subsequent sessions. All adjusted BI median scores (change from baseline) and corresponding 95% confidence intervals are shown in Figure 3, and indicate that the change in BI median score between baseline and 4 weeks post-GVS was statistically significant in the 1 active treatment arm (though analysis of the ranked data showed that this change was also statistically significant in both other treatment arms). The pattern of overlapping confidence intervals indicates that there were no reliable differences between treatment arms. Summary data for the 1 active condition indicated that improvement was most evident on the bathing, bladder, bowels, and transfer (from bed to chair) sub-scales (see Figure 4). As with the BIT data, the exploratory analysis indicated that Time since Stroke did not significantly affect outcome (see Table 11).

Table 9

Treatment regimen
1 Active5 Active10 Active
BaselineMean42.953.871.3
SD27.432.826.8
Median405080
Minimum0520
Maximum90100100
Range909580
N121615
Session 10Mean49.660.862.3
SD24.129.131.0
Median507065
Minimum52015
Maximum75100100
Range708085
N131815
Week 1Mean59.165.361.1
SD27.327.421.9
Median707055
Minimum02025
Maximum85100100
Range858075
N111514
Week 2Mean57.553.263.3
SD30.927.425.9
Median604565
Minimum51525
Maximum9595100
Range908075
N121415
Week 4Mean64.356.966.4
SD24.525.626.5
Median67.557.570
Minimum01525
Maximum90100100
Range908575
N141614

Summary of BI scores.

Table 10

Analysis of covariance (p-values)
TreatmentTreatment (linear)BaselineAgePatient status
Week 40.3610.172<0.0010.5680.709
Session 100.4940.581<0.0010.3380.746
Week 10.5660.405<0.0010.5910.288
Week 20.8940.650<0.0010.4260.687

Results from statistical analysis of Barthel Index.

Figure 3

Figure 4

Table 11

Analysis of covariance (p-values)
TreatmentTreatment (linear)BaselineAgePatient statusTime since stroke
Week 40.4060.178<0.0010.6300.6790.934

Results from exploratory statistical analysis of Barthel Index including time since stroke as a co-variate.

Adverse events and participant satisfaction

Table 12 presents summary data collected from participants' diary cards before and during the stimulation period. Relative to baseline, there was little evidence in any treatment group of increased sickness, headache, tiredness, dizziness, pain behind ears or visual disturbance. Participants in all treatment arms reported favorable opinions on the satisfaction questionnaire (see Table 13).

Table 12

1 Active5 Active10 Active
BaselineDays 1–5Days 6–10BaselineDays 1–5Days 6–10BaselineDays 1–5Days 6–10
SICKNESS
Not at all799101091088
A little200101011
Moderately000000000
Very much000000010
HEADACHE
Not at all679578976
A little110410002
Moderately010210130
Very much000012001
TIREDNESS
Not at all111665100
A little013011135
Moderately454312532
Very much321222342
DIZZINESS
Not at all899111091097
A little000000011
Moderately000001001
Very much000000000
PAIN BEHIND EARS
Not at all8991110101098
A little000000010
Moderately000000001
Very much000000000
VISUAL DISTURBANCE
Not at all13121212131210911
A little121000242
Moderately000111100
Very much000101111

Summary of participant diary data.

Table 13

QuestionResponseTreatment regimen
9 Sham 1 Active5 Sham 5 Active10 Active
1. How has the course of treatment affected your awareness of your surroundings?Much better474
A little better677
No different333
A little worse000
Much worse000
2. In an overall, general sense how has the treatment made you feel about yourself?Much better352
A little better326
No different796
A little worse010
Much worse000
3. Was the treatment worth the effort of attending all the sessions?Definitely yes121411
Probably yes132
Not sure001
Probably no000
Definitely no00
4. Are you happy with how the researchers behaved toward you?Definitely yes131814
Probably yes000
Not sure000
Probably no000
Definitely no000
5. If a friend were in need of similar help, would you recommend our treatment to him or her?Definitely yes12189
Probably yes104
Not sure001
Probably no000
Definitely no000

Participant satisfaction questionnaire.

Values denote participant counts.

Discussion

The marked improvement in mean BIT scores observed straight after the last stimulation session was still evident 4 weeks later. The scores recorded in this final follow-up were, for all treatment arms combined, 28% greater than those at baseline and gave rise to a large effect size (Cohen's d >1.0). This improvement was observed within all treatment arms, was evident on all BIT sub-tests and was not affected by time since stroke. For participants in the single treatment arm, improvement transferred beyond the diagnostic measure of the BIT to the BI, a widely used, albeit relatively crude, measure of activities of daily living. Here there was a median improvement of 20%—a change considered to be clinically important, with changes most noticeable on the continence, bathing and transfer sub-scales. These changes were achieved in the absence of any reported adverse events and at a high level of participant compliance and satisfaction.

The comparable efficacy of a single versus multiple stimulation sessions is perhaps surprising given that most forms of cognitive rehabilitation rely on repeated administration. However, as mentioned in the Introduction, three, small GVS studies have shown carry-over from a single session (Kerkhoff et al., 2011; Schmidt et al., 2013; Zubko et al., 2013). This may partly stem from the fact that the vestibular nerve is stimulated many thousands of times during a single 25–30 min session. This rate of stimulus repetition is much higher than that achieved with conventional behavioral interventions such as visual scanning therapy and contralesional limb activation and may, over a single session, be sufficient to induce long-term change in synaptic transmission (see Cooke and Bliss, 2006). The fact that these changes can be preferentially lateralized to the lesioned hemisphere via bipolar, binaural GVS may be particularly relevant given that neglect is associated with chronic under- and over-activation of the right and left hemisphere attentional systems respectively (Kinsbourne, 1977). The propensity for cortical change may be further enhanced by the distal up-regulation of key neurotransmitters within the brainstem during vestibular stimulation. Increased concentration of glutamate, a transmitter deemed especially important for NMDA-mediated synaptic excitability, has been observed within ascending pathways of the parabrachial nuclei and solitary tract during stimulation (Cai et al., 2007). Allied changes in serotonin release from the medial vestibular nuclei (Ma et al., 2007) and acetylcholine from hippocampal structures (Horii et al., 1994) may further facilitate recovery by heightening general arousal and alleviating co-morbid affective and cognitive disorders (Wilkinson et al., 2012).

On a cautionary note, the absence of a contemporaneous no-stimulation condition raises the question as to whether the improvement reported here was simply the result of natural recovery, practice and/or placebo. Such accounts cannot yet be ruled out with certainty. We chose not to include a no-stimulation condition because differences were expected between the treatment arms which would, given the blinding and minimization procedures employed, be sufficient to attribute at least some of the carry-over to GVS and thereby demonstrate proof-of-concept. Although treatment differences were not found, we believe it too coincidental for so many of the participants' natural recovery to be time-locked to the ~2 week period between baseline assessment and the final day of stimulation, not least given their sub-acute and chronic status (recall that all patients were at least 6 weeks post-onset). If the initial improvement reflected increased familiarity with the test materials then, contrary to the results, one might have expected further improvement at the later sessions. Against a general practice effect, we also note that the test/retest reliability of the BIT across sessions spaced approximately 2 weeks apart (i.e., the time window in which most recovery occurred here) is high, yielding a correlation of 0.99 (Wilson et al., 1987). Regarding the potential influence of placebo, other neurostimulation studies have reported minimal placebo effects within this population (Nyffeler et al., 2009; Cazzoli et al., 2012; Koch et al., 2012). Aside from the use of blinding to counter placebo effects, the general absence of a strong placebo is also taken to reflect neglect patients' characteristic lack of affect and self-awareness. It also seems unlikely that any placebo occurring straight after stimulation would persist with the same intensity 1 month later, as observed here. Nevertheless, if this was the case then such a powerful placebo is, in its own right, worthy of further clinical investigation.

Aside from including a no-stimulation condition, we propose that further study should incorporate longer-term follow-up assessments. It remains possible that a greater number of sessions are more efficacious than a single one, but that longer follow-ups, perhaps in the order of months rather than weeks, are needed before this advantage becomes apparent. A second design issue concerns the best current amplitude to apply. We chose a 1 mA waveform because this is usually subliminal in older stroke patients yet known to modulate relevant neurophysiological and visual functions (Wilkinson et al., 2005, 2008, 2010, 2012; Zubko et al., 2013). But studies that perturb the vestibular stimulation via the more potent stimulus of ice-cold irrigation of the external ear canal have tended to eliminate (albeit transiently) rather than merely reduce neglect (Rubens, 1985; Cappa et al., 1987). The implication is that greater electrical currents may exert stronger relief than observed. The problem is that greater currents induce distracting side-effects, such as nausea and vertigo, and increase the risk of electrode burn. Future study therefore needs to establish if higher currents affect patient compliance within an acceptable margin. To this end, Utz et al. (2011b) recently demonstrated that, despite increased mild itching and tingling at the electrode sites, neglect patients were just as willing to receive GVS at 1.5 mA (super-sensory) as 0.6 mA. A key question is whether this willingness persists at even higher and potentially more efficacious levels. A final recommendation for future study is to incorporate multiple baseline assessments to better capture the rate of natural recovery. We excluded these assessments because the patients were sub-acute and the rate of natural recovery was assumed to be broadly comparable across treatment arm. But such repeat assessments must be included if studies are to now move beyond proof-of-concept and more accurately estimate treatment effect.

In closing, the current data endorse the growing sense that non-invasive neurostimulation may offer a viable alternative to pharmacological and behavioral interventions for neglect (Utz et al., 2010; Oliveri, 2011). Most neurostimulation research has focused on the potential benefits of transcranial direct current stimulation and transcranial magnetic stimulation. These techniques have also shown preliminary efficacy in neglect patients (see Müri et al., 2013). As in the present study, one recent TMS trial administered 10 daily sessions of stimulation and showed comparable improvement (23%) in BIT scores at 1 month follow-up (Koch et al., 2012). A subsequent study found that just 2 sessions of theta burst activity were sufficient to induce improvement for up to 3 weeks on the Catherine Bergego cale (Cazzoli et al., 2012), a measure of activities of daily living (Azouvi et al., 2003). However, the clinical application of these allied techniques still lacks systematic investigation—stimulation protocols need to be finessed, mechanistic bases elucidated, and too few studies incorporate adequate sample sizes, long follow-ups and measures of functional transfer (Müri et al., 2013; Yang et al., 2013). One advantage of GVS over these other stimulation methods is that delivery is simpler because there is no uncertainty about where on the scalp to apply stimulation—the electrodes are simply fastened to the mastoid processes. There is also no reported increase in seizure risk—if anything vestibular stimulation may reduce the likelihood of seizure onset (Kantner et al., 1982). In addition, GVS is cheap (relying on just a small battery, a simple micro-processor that can manage several stimulation parameters, two leads and a pair of electrodes), portable and suitable for home-based administration. Given the empirical data reported in the current study, we therefore recommend a further stage of optimization and efficacy testing before direct comparisons are made between GVS and these other emerging treatment options.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Statements

Acknowledgments

We wish to thank all participants and clinical care teams for their kind co-operation, and are grateful to Serena Vanzan and Maria Gallagher for assisting with data collection. This work was supported by a Medical Research Council Developmental Clinical Studies award (G1001222), and from the Flexibility & Sustainability Fund of East Kent Hospitals University NHS Foundation Trust.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    AzouviP.OlivierS.de MontetyG.SamuelC.Louis-DreyfusA.TesioL. (2003). Behavioral assessment of unilateral neglect: study of the psychometric properties of the Catherine Bergego Scale. Arch. Phys. Med. Rehabil. 84, 5157. 10.1053/apmr.2003.50062

  • 2

    BalabanC.JacobR.FurmanJ. (2011). Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev. Neurother. 11, 379394. 10.1586/ern.11.19

  • 3

    BeckA.SteerR.BrownG. (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.

  • 4

    BenseS.ThomasS.YousryT.BrandtT.DieterichM. (2001). Multisensory cortical signal increases and decreases during galvanic vestibular stimulation (fMRI). J. Neurophysiol. 85, 886899.

  • 5

    BowenA.HazeltonC.PollockA.LincolnN. B. (2013). Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst. Rev. 7:CD003586. 10.1002/14651858.CD003586.pub3

  • 6

    CaiY. L.MaW. L.LiM.GuoJ. S.LiY. Q.WangL. G.et al. (2007). Glutamatergic vestibular neurons express Fos after vestibular stimulation and project to the NTS and the PBN in rats. Neurosci. Lett. 417, 132137. 10.1016/j.neulet.2007.01.079

  • 7

    CallahanC.UnverzagtF.HuiS.PerkinsA.HendrieH. (2002). Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med. Care40, 771781. 10.1097/00005650-200209000-00007

  • 8

    CappaS.SterziR.VallarG.BisiachE. (1987). Remission of hemineglect and anosognosia during vestibular stimulation. Neuropsychologia25, 775782. 10.1016/0028-3932(87)90115-1

  • 9

    CazzoliD.MüriR. M.SchumacherR.von ArxS.ChavesS.GutbrodK.et al. (2012). Theta burst stimulation reduces disability during the activities of daily living in spatial neglect. Brain135, 34263439. 10.1093/brain/aws182

  • 10

    CoatsA. C. (1972). Limit of normal of the galvanic body-sway test. Ann. Otol. Rhinol. Laryngol. 81, 410416.

  • 11

    CookeS.BlissT. (2006). Plasticity in the human central nervous system. Brain129, 16591673. 10.1093/brain/awl082

  • 12

    GillenR.TennenH.McKeeT. (2005). Unilateral spatial neglect: relation to rehabilitation outcome in patients with right hemisphere stroke. Arch. Phys. Med. Rehabil. 86, 763767. 10.1016/j.apmr.2004.10.029

  • 13

    HalliganP.WilsonB.CockburnJ. (1987). A short screening test for visual neglect in stroke patients. Int. Disabil. Stud. 12, 9599. 10.3109/03790799009166260

  • 14

    HoffmanR.CavusI. (2002). Slow transcranial magnetic stimulation, long-term depotentiation and brain hyperexcitability disorders. Am. J. Psychiatry159, 10931102. 10.1176/appi.ajp.159.7.1093

  • 15

    HoriiA.TakedaN.MochizukiT.Okakura-MochizukiK.YamamotoY.YamatodaniA. (1994). Effects of vestibular stimulation on acetylcholine release from rat hippocampus: an in vivo microdialysis study. J. Neurophysiol. 72, 605611.

  • 16

    JehkonenM.AhonenJ.-P.KoivistoA.-M.LaippalaP.VilkkiJ.MolnárG. (2000). Visual neglect as a predictor of functional outcome one year after stroke. Acta Neurol. Scand. 101, 195201. 10.1034/j.1600-0404.2000.101003195.x

  • 17

    KalraL.PerezI.GuptaS.WittinkM. (1997). The influence of visual neglect on stroke rehabilitation. Stroke28, 13861391. 10.1161/01.STR.28.7.1386

  • 18

    KantnerR. M.ClarkD. L.AtkinsonJ.PaulsonG. (1982). Effects of vestibular stimulation in seizure-prone children. An EEG study. Phys. Ther. 62, 1621.

  • 19

    KatzN.Hartman-MaeirA.RingH.SorokerN. (1999). Functional disability and rehabilitation outcome in right hemisphere damaged patients with and without unilateral spatial neglect. Arch. Phys. Med. Rehabil. 80, 379384. 10.1016/S0003-9993(99)90273-3

  • 20

    KerkhoffG.HildebrandtH.ReinhartS.KardinalM.DimovaV.UtzK. S. (2011). A long-lasting improvement of tactile extinction after galvanic vestibular stimulation: two sham-stimulation controlled case studies. Neuropsychologia49, 186195. 10.1016/j.neuropsychologia.2010.11.014

  • 21

    KinsbourneM. (1977). Hemi-neglect and hemispheric rivalry in Hemi-Inattention and Hemispheric Specialization, eds WeinsteinE. A.FriedlandR. P. (New York, NY: Raven Press).

  • 22

    KleinjungT.EichhammerP.LangguthB.JacobP.MarienhngenJ.HajakG.et al. (2005). Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolayrngol. Head Neck Surg. 132, 566569. 10.1016/j.otohns.2004.09.134

  • 23

    KochG.BonnìS.GiacobbeV.BucchiG.BasileB.LupoF.et al. (2012). θ-burst stimulation of the left hemisphere accelerates recovery of hemispatial neglect. Neurology78, 2430. 10.1212/WNL.0b013e31823ed08f

  • 24

    MaF.LuiJ.-X.LiX.-P.MaoJ.-J.ZhangQ.-D.JiaH.-B.et al. (2007). Effects of caloric vestibular stimulation on serotoninergic system in the media vestibular nuclei of guinea pigs. Chin. Med. J. 120, 120124.

  • 25

    MahoneyF.BarthelD. (1965). Functional evaluation: the barthel index. Md. State Med. J. 14, 6165.

  • 26

    McKayD.BrookerR.GiacominP.RiddingM.MilesT. (2002). Time course of induction of increase human cortex excitability by nerve stimulation. Neuroreport13, 12711273. 10.1097/00001756-200207190-00011

  • 27

    MillerS.NgoT. (2007). Studies of caloric vestibular stimulation: implications for the cognitive neurosciences, the clinical neurosciences and neurophilosophy. Acta Neuropsychiatr. 19, 183203. 10.1111/j.1601-5215.2007.00208.x

  • 28

    MüriR. M.CazzoliD.NefT.MosimannU. P.HopfnerS.NyffelerT. (2013). Non-invasive brain stimulation in neglect rehabilitation: an update. Front. Hum. Neurosci. 7:248. 10.3389/fnhum.2013.00248

  • 29

    NaeserM.MartinP.HoM.TregliaE.KaplanE.BashirS.et al. (2012). Transcranial magnetic stimulation and aphasia rehabilitation. Arch. Phys. Med. Rehabil. 93, S26S34. 10.1016/j.apmr.2011.04.026

  • 30

    NijboerT.van de PortI.SchepersV.PostM.Visser-MeilyA. (2013). Predicting functional outcome after stroke: the influence of neglect on basic activities in daily living. Front. Hum. Neurosci. 7:182. 10.3389/fnhum.2013.00182

  • 31

    NyffelerT.CazzoliD.HessC. W.MüriR. M. (2009). One session of repeated parietal theta burst stimulation trains induces long-lasting improvement of visual neglect. Stroke40, 27912796. 10.1161/STROKEAHA.109.552323

  • 32

    OhnS. H.ParkI.YooK.KoM. H.ChoiK. P.KimG.et al. (2008). Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport8, 4347. 10.1097/WNR.0b013e3282f2adfd

  • 33

    OliveriM. (2011). Brain stimulation procedures for treatment of contralesional spatial neglect. Restor. Neurol. Neurosci. 29, 421425. 10.3233/RNN-2011-0613

  • 34

    PaolucciS.AntonucciG.GrassoM.PizzamiglioL. (2001). The role of unilateral spatial neglect in rehabilitation of right brain-damaged ischemic stroke patients: a matched comparison. Arch. Phys. Med. Rehabil. 82, 743749. 10.1053/apmr.2001.23191

  • 35

    RingmanJ.SaverJ.WoolsonR.ClarkeW.AdamsH. (2004). Frequency, risk factors, anatomy and course of unilateral neglect in an acute stroke cohort. Neurology10, 468474. 10.1212/01.WNL.0000133011.10689.CE

  • 36

    RobertsonI.HalliganP. (1999). Spatial Neglect: A Clinical Handbook for Diagnosis and Treatment. Hove: Psychology Press.

  • 37

    RorsmanI.MagnussonM.JohanssonB. B. (1999). Reduction of visuo-spatial neglect with vestibular galvanic stimulation. Scand. J. Rehabil. Med. 31, 117124. 10.1080/003655099444632

  • 38

    RubensA. (1985). Caloric stimulation and unilateral neglect. Neurology35, 10191024. 10.1212/WNL.35.7.1019

  • 39

    SchmidtL.UtzK. S.DepperL.AdamsM.SchaadtA. K.ReinhartS.et al. (2013). Now you feel both: galvanic vestibular stimulation induces lasting improvements in the rehabilitation of chronic tactile extinction. Front. Hum. Neurosci. 7:9. 10.3389/fnhum.2013.00090

  • 40

    ShindoK.SuglyamaK.HuabaoL.NishijimaK.KondoT.IzumiS. (2006). Long-term effect of low frequency repetitive transcranial magnetic stimulation over the unaffected posterior parietal cortex in patients with unilateral spatial neglect. J. Rehabil. Med. 38, 6567. 10.1080/16501970500441807

  • 41

    SuzukiH.KitanoR.ItoT.KitanishiY.YazawaT.OgawaT.et al. (2001). Cortical and subcortical vestibular response to caloric stimulation detected by functional magnetic resonance imaging. Brain Res. Cogn. Brain Res. 12, 441444. 10.1016/S0926-6410(01)00080-5

  • 42

    UtzK. S.KellerI.KardinalM.KerkhoffG. (2011a). Galvanic vestibular stimulation reduces the pathological rightward line bisection error in neglect - a sham stimulation-controlled study. Neuropsychologia49, 12191225. 10.1016/j.neuropsychologia.2011.02.046

  • 43

    UtzK.KorlussK.SchmidtL.RosenthalA.OppenländerK.KellerI.et al. (2011b). Minor adverse effects of galvanic vestibular stimulation in persons with stroke and healthy individuals. Brain Inj. 25, 10581069. 10.3109/02699052.2011.607789

  • 44

    UtzK. S.DimovaV.OppenländerK.KerkhoffG. (2010). Electrified minds: transcranial direct current stimulation (tDCS) and galvanic vestibular stimulation (GVS) as methods of non-invasive brain stimulation in neuropsychology–a review of current data and future implications. Neuropsychologia48, 27892810. 10.1016/j.neuropsychologia.2010.06.002

  • 45

    WilkinsonD.FergusonH.WorleyA. (2012). Galvanic vestibular stimulation modulates the electrophysiological response during face processing. Vis. Neurosci. 15, 18. 10.1017/S0952523812000235

  • 46

    WilkinsonD.KoP.KilduffP.McGlincheyR.MilbergW. (2005). Improvement of a face perception deficit via subsensory galvanic vestibular stimulation. J. Int. Neuropsychol. Soc. 11, 925929. 10.1017/S1355617705051076

  • 47

    WilkinsonD.NichollsS.PattendenC.KilduffP.MilbergP. (2008). Galvanic vestibular stimulation speeds visual memory recall. Exp. Brain Res. 18, 243248. 10.1007/s00221-008-1463-0

  • 48

    WilkinsonD.ZubkoO.DegutisJ.MilbergW.PotterJ. (2010). Improvement of a figure copying deficit during subsensory galvanic vestibular stimulation. J. Neuropsychol. 4, 107118. 10.1348/174866409X468205

  • 49

    WilsonB.CockburnJ.HalliganP. (1987). Behavioural Inattention Test Manual. Fareham: Thames Valley Testing Co.

  • 50

    YangN. Y.ZhouD.ChungR. C.Li-TsangC. W.FongK. N. (2013). Rehabilitation interventions for unilateral neglect after stroke: a systematic review from 1997 through 2012. Front. Hum. Neurosci. 10:187. 10.3389/fnhum.2013.00187

  • 51

    ZubkoO.Wilkinson, D, LangstonD.SakelM. (2013). The effect of repeated sessions of galvanic vestibular stimulation on target cancellation in visuo-spatial neglect: preliminary evidence from two cases. Brain Inj. 27, 613619. 10.3109/02699052.2013.767938

Summary

Keywords

stroke, neuro-stimulation, clinical trial, hemi-inattention, rehabilitation

Citation

Wilkinson D, Zubko O, Sakel M, Coulton S, Higgins T and Pullicino P (2014) Galvanic vestibular stimulation in hemi-spatial neglect. Front. Integr. Neurosci. 8:4. doi: 10.3389/fnint.2014.00004

Received

04 October 2013

Accepted

09 January 2014

Published

29 January 2014

Volume

8 - 2014

Edited by

Christophe Lopez, Centre National de La Recherche Scientifique, France

Reviewed by

Arnaud Saj, University Hospital of Geneva, Switzerland; Kathrin S. Utz, Friedrich-Alexander University Erlangen-Nuremberg, Germany

Copyright

*Correspondence: David Wilkinson, School of Psychology, University of Kent, Canterbury, Kent CT2 7NP, UK e-mail:

This article was submitted to the journal Frontiers in Integrative Neuroscience.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics